The final countdown

It's seven days until otc regulations come into effect.
key questions that nuheara management need to answer (hopefully they do).
has pro (or its new incarnation) achieved fda approval?
what inventory have they stockpiled to mass produce the hearing aids?
what are the left over max inventory levels?
will these be written off?
how will they finance the production runs?
how will they advertise?
are they planning to increase debt?
are the hearing aids different form/shape to max?
why did they really consolidate?
is the consolidation linked to us listing?
where is the us listing at?
if no us listing will they be capital raising soon?
what deals do they have to commercialise their op in non hearing aid industry?
deals with Sonova, nhs, oto, specsavers, Walmart, Walgreens, Amazon, best buys, have not gained any significant sales traction. Why? Why will this time be different?
samsungs take over bid initially fell through due to mining holdings. Now they are gone has nuh been approached for a take over, was the consolidation part of a broader strategy to protect the company from a take over or does it make the company more attractive to other firms?
is it managements goal to sell the company. If so what price? Are their any bonuses related to selling of company and if so what price are they set at?
how much improvement do the nuh hearing aids give over noise cancelling earbuds? Have they conducted comparatively studies?
what technical advantages and in turn commercial advantages do the new hearing aids have?